Preclinical evaluation of the HSP-90 inhibitor 17AAG in Hodgkin’s and non-Hodgkin’s lymphomas: Induction of apoptosis and potentiation of chemotherapy cytotoxicity

6570 Background: Heat shock protein (HSP)-90 is an intracellular protein that chaperons several client oncoproteins important for the neoplastic process, making it a promising molecular target for ...